I agree that content from Twitter will be displayed to me.

Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Projects
K4DD
Ecker, G. (Project Lead), Grandits, M. (Co-Lead) & Dangl, A. (Admin)
1/11/12 → 31/10/17
Project: Research funding
EU-ToxRisk: EU-ToxRisk
Ecker, G. (Project Lead), Grandits, M. (Scientific Project Staff), Dangl, A. (Admin), Zdrazil, B. (Scientific Project Staff), Jain, S. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)
1/01/16 → 31/12/21
Project: Research funding
TransQST: Translational quantitative systems toxicology to improve the understanding of the safety of medicines
Ecker, G. (Project Lead), Grandits, M. (Admin), Dangl, A. (Admin), Füzi, B. (Scientific Project Staff) & Schwarzenböck, M. (Project Staff)
1/01/17 → 30/06/22
Project: Research funding
